Tinnitus
rTMS for Tinnitus
Tinnitus, characterized by the perception of sound without an external source, affects approximately 10-15% of the adult population globally. In Canada, nearly 360,000 adults report significant symptoms of tinnitus, with 150,000 experiencing severe distress. (Canadian Tinnitus Foundation, 2020)
Tinnitus contributes to reduced concentration and productivity, with many individuals reporting challenges in maintaining focus in the workplace. (Hall et al., 2018) Severe cases can lead to absenteeism and the inability to sustain employment.
The constant perception of ringing, buzzing, or other sounds significantly impacts sleep, mental health, and overall quality of life. Tinnitus is closely associated with anxiety and depression, further exacerbating its functional impact. (Shargorodsky et al., 2010)
What are the Current Treatments?
Current treatments for tinnitus aim to manage symptoms rather than eliminate the condition. These include:
- Sound therapy: Devices that generate low-level noise to mask tinnitus.
- Cognitive-behavioral therapy (CBT): Aims to reduce the emotional distress caused by tinnitus.
- Medications: Off-label use of antidepressants and anxiolytics to address associated anxiety and depression. (Jastreboff et al., 2010)
While these options provide some relief, they are often insufficient for severe cases.
Challenges with our Current Options
Challenges with traditional treatments include variability in effectiveness, high recurrence rates, and limited targeting of the neurological mechanisms underlying tinnitus. Many individuals continue to experience significant distress despite interventions. (Hoare et al., 2014)
How rTMS Can Help
Transcranial Magnetic Stimulation (TMS) Therapy targets the auditory cortex, reducing hyperactivity in neural pathways associated with tinnitus perception. This neuromodulation approach addresses the neurological basis of tinnitus, offering relief from symptoms. (Lefaucheur et al., 2014)
Studies show that low frequency rTMS applied to the auditory cortex significantly reduces tinnitus severity. Randomized controlled trials have demonstrated improvements in the Tinnitus Handicap Inventory (THI) scores following rTMS treatment. (Langguth et al., 2010) Meta-analyses support rTMS as a promising non-invasive treatment for tinnitus, with sustained benefits observed in some patients. (Chen et al., 2017)
Although rTMS is not yet FDA or Health Canada-approved for tinnitus, its off-label use is supported by an increasing body of evidence.
Struggling with persistent tinnitus?
Contact Magnetix Health today to explore how rTMS can help restore your peace of mind.
Book Now!
